(Q39468649)

12 September 2017

1 reference

title

Effect of drug therapy on survival in chronic congestive heart failure (English)

1 reference

12 September 2017

0 references

congestive heart failure

1 reference

Furberg CD

1

1 reference

PubMed ID

2898890

12 September 2017

Yusuf S

series ordinal

2

1 reference

PubMed ID

2898890

12 September 2017

language of work or name

English

0 references

publication date

1 July 1988

1 reference

American Journal of Cardiology

12 September 2017

1 reference

12 September 2017

62

1 reference

12 September 2017

2

1 reference

12 September 2017

41A-45A

1 reference

Effect of vasodilators on survival in chronic congestive heart failure

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Effect of the vasodilator trimazosin versus placebo on exercise performance in chronic left ventricular failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Long-term treatment of severe chronic heart failure with captopril: a double-blind, randomized, placebo-controlled, long-term study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Placebo-controlled study of lisinopril in congestive heart failure: a multicentre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Captopril in heart failure. A double blind controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Long-term therapy of heart failure with prazosin: a randomized double blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Clinical efficacy of hydralazine in chronic heart failure: one-year double-blind placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Nitrate Therapy for Congestive Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Long-term ambulatory therapy with prazosin versus placebo for chronic heart failure: relation between clinical response and left ventricular function at rest and during exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Efficacy of prazosin in the management of chronic congestive heart failure: A 6-month randomized, double-blind, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Long-Term Vasodilator Therapy with Trimazosin in Chronic Cardiac Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Drug-induced conditioning in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Vasodilator and inotropic therapy for severe chronic heart failure: Passion and skepticism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980084-5

10.1016/S0002-9149(88)80084-5

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference

PubMed ID

2898890